Is osteoarthritis a metabolic disorder?

Area of Science:

• Inflammation research
• Metabolic syndrome
• Osteoarthritis

Background:

• Obesity is a known risk factor for osteoarthritis (OA), affecting even non-weight-bearing joints.
• Adipose tissue-associated inflammation is a potential mechanism linking obesity to OA.
• Metabolic syndrome (MetS) components are associated with knee, hip, and hand OA.

Purpose of the Study:

• To review the shared inflammatory mechanisms between obesity, MetS, and OA.
• To examine the association between MetS and OA, including higher mortality in knee OA.
• To identify areas for future research in OA and MetS.

Main Methods:

• Literature review of published evidence.
• Analysis of the relationship between adipose tissue inflammation, MetS, and OA.
• Synthesis of current understanding and identification of research gaps.

Main Results:

• Adipose tissue-associated inflammation is implicated in the shared pathogenesis of obesity-related OA.
• MetS components are linked to OA development and increased mortality, particularly in knee OA.
• A need exists for cohort studies on early metabolic changes in high-risk populations.

Conclusions:

• Inflammatory pathways are crucial in understanding the link between obesity, MetS, and OA.
• Further research is required to elucidate OA-associated mortality and identify preventative strategies.
• Well-designed cohort studies are essential for advancing OA and MetS research.